Haemangioma Congenital

also: Hemangioma Congenital

1 drug8 FAERS reportsMedDRA PT

GET

/api/v1/reaction/haemangioma-congenital

Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

Drugs reporting Haemangioma Congenital (1)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1Indocyanine Green87.0%

What this is

Haemangioma Congenital is a MedDRA Preferred Term reported on FAERS adverse-event submissions. Each entry below is one drug from the dataset whose FAERS reports mention this reaction.

Try the API

cURLbash

curl https://pharmacopeia.dev/api/v1/reaction/haemangioma-congenital

Source

Source: openFDA · FAERS
Coding: MedDRA Preferred Term
Aliases: Hemangioma Congenital

open.fda.gov/data/faers/

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Haemangioma Congenital

Drugs reporting Haemangioma Congenital (1)

Search pharmacopeia